BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Business

  Cerveau Technologies Signs Research Agreement With VU Medical Center Amsterdam

  These research projects are for studies of an early stage imaging agent (MK-6240) to be used in Positron Emission Tomography (PET) scans for assessing the status and progression of neurofibrillary tangles (NFTs) in the brain.

  December 6, 2017

   · 

  2 min read
• Business

  Liminal VR Collaborates With the Florey Institute of Neuroscience and Mental Health on Unprecedented Colour-Emotion Study Using Virtual Reality

  Liminal and Florey aim to have between 750 and 1,000 participants by the end of the year.

  December 6, 2017

   · 

  3 min read
• Business

  Viriom Announces New Director Appointment

  Viriom is pleased to announce the appointment of Augustine Lawlor as Director of Viriom.

  December 6, 2017

   · 

  2 min read
• 3dbiosurfaces Technologies, LLC and STRATEC Announce the Commercial Release of 3D NS-NC Slide- the New Standard of Microarray Substrates

  3dbiosurfaces and STRATEC Consumables GmbH, a wholly owned subsidiary of STRATEC, announced today the release of the first commercially available microarray substrate based on 3dbiosurfaces patented and patent-pending technologies.

  December 6, 2017

   · 

  2 min read
• Drug Development

  Nemaura Announces Successful SugarBEAT Interim Precision Study Results

  The results indicated that over 80% of all data between the skin-patches at each time point were within 8% of each other, with an average precision of 1.07.

  December 6, 2017

   · 

  3 min read
• 

  Genetown

  Editas Medicine Prices $50M Offering of Common Stock

  Morgan Stanley is acting as sole book running manager for the offering.

  December 6, 2017

   · 

  3 min read
• Business

  COMPASS Pathways Partners With Worldwide Clinical Trials to Conduct World’s First Large-scale Clinical Trials in Psilocybin Therapy for Treatment-resistant Depression

  December 6, 2017

   · 

  5 min read
• Business

  TetraGenetics and ModiQuest Collaborating for the Discovery of Therapeutic Antibodies Against KCa3.1

  The alliance is focused on the discovery of novel monoclonal antibodies against KCa3.1, a well-validated target for fibrosis, vasculoproliferative disorders and immunomodulation to treat autoimmune and inflammatory disorders.

  December 6, 2017

   · 

  3 min read
• SYGNIS AG Launches TruePrime Apoptotic Cell Free DNA Amplification Kit for the Liquid Biopsy Market

  The kit enables accurate DNA amplification using cfDNA obtained from plasma, serum, urine, CSF, or many other bodily fluids.

  December 6, 2017

   · 

  3 min read
• Business

  Clinigen Plc Directorate Change

  Clinigen announces that Chris Rigg has resigned with immediate effect as a director to seek a CEO role elsewhere.

  December 6, 2017

   · 

  1 min read